Literature DB >> 23600869

The RNA polymerase of influenza a virus: mechanisms of viral transcription and replication.

E Fodor1.   

Abstract

The influenza A virus RNA genome segments are packaged in ribonucleoprotein complexes containing RNA polymerase and nucleoprotein. The ribonucleoprotein is involved in the transcription of viral genes and replication of the viral RNA genome in the nucleus of the infected cells, and represents the minimal transcriptional and replicative machinery of an influenza virus. During transcription, the viral RNA polymerase synthesizes capped and polyadenylated mRNA using 5΄ capped RNA primers. During replication, the viral RNA polymerase generates a complementary RNA (cRNA) replication intermediate, a full-length complement of the vRNA that serves as a template for the synthesis of new copies of vRNA. The nucleoprotein is also an essential component of the viral transcriptional machinery. The molecular determinants of the transcriptional and replicative activities of the viral RNA polymerase are not fully understood, but recent data suggest that transcription is performed by a cis-acting RNA polymerase, forming part of the ribonucleoprotein complex, while replication might be carried out by a trans-acting RNA polymerase. Viral as well as cellular factors are known to be involved in the regulation of the activities of the RNA polymerase, e.g. the viral nuclear export protein has been shown to regulate the accumulation of viral transcription and replication products. The viral transcriptional machinery represents an attractive target for the development of antiviral drugs and lead compounds targeting nucleoprotein and the PA endonuclease domain of the RNA polymerase have already been identified.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600869     DOI: 10.4149/av_2013_02_113

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  84 in total

1.  A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.

Authors:  Wen-Chi Su; Shih-Feng Hsu; Yi-Yuan Lee; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Biological activities of 'noninfectious' influenza A virus particles.

Authors:  Christopher B Brooke
Journal:  Future Virol       Date:  2014-01       Impact factor: 1.831

Review 3.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

4.  The avian-origin PB1 gene segment facilitated replication and transmissibility of the H3N2/1968 pandemic influenza virus.

Authors:  Isabel Wendel; Dennis Rubbenstroth; Jennifer Doedt; Georg Kochs; Jochen Wilhelm; Peter Staeheli; Hans-Dieter Klenk; Mikhail Matrosovich
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

5.  DnaJA1/Hsp40 is co-opted by influenza A virus to enhance its viral RNA polymerase activity.

Authors:  Mengmeng Cao; Candong Wei; Lili Zhao; Jingfeng Wang; Qiannan Jia; Xue Wang; Qi Jin; Tao Deng
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

6.  AZT acts as an anti-influenza nucleotide triphosphate targeting the catalytic site of A/PR/8/34/H1N1 RNA dependent RNA polymerase.

Authors:  Nataraj Sekhar Pagadala
Journal:  J Comput Aided Mol Des       Date:  2019-02-09       Impact factor: 3.686

7.  Structural insight into cap-snatching and RNA synthesis by influenza polymerase.

Authors:  Stefan Reich; Delphine Guilligay; Alexander Pflug; Hélène Malet; Imre Berger; Thibaut Crépin; Darren Hart; Thomas Lunardi; Max Nanao; Rob W H Ruigrok; Stephen Cusack
Journal:  Nature       Date:  2014-11-19       Impact factor: 49.962

8.  Structure of influenza A polymerase bound to the viral RNA promoter.

Authors:  Alexander Pflug; Delphine Guilligay; Stefan Reich; Stephen Cusack
Journal:  Nature       Date:  2014-11-19       Impact factor: 49.962

9.  Ceramide Suppresses Influenza A Virus Replication In Vitro.

Authors:  Nadia Soudani; Rouba Hage-Sleiman; Walid Karam; Ghassan Dbaibo; Hassan Zaraket
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

10.  Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.

Authors:  Min-Suk Song; Gyanendra Kumar; William R Shadrick; Wei Zhou; Trushar Jeevan; Zhenmei Li; P Jake Slavish; Thomas P Fabrizio; Sun-Woo Yoon; Thomas R Webb; Richard J Webby; Stephen W White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.